Position in LQDA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,701,224
+$3,825,238 QoQ
Shares Held
204,060
+81.6% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $52,013,067 across 12 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,089,480 | $14,718,874 | |
| 2 | LQDA |
Liquidia Corp
This page
|
204,060 | $7,701,224 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,156,958 | $6,710,356 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
222,840 | $5,332,561 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
355,929 | $4,424,197 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
6,160 | $3,652,756 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
47,568 | $2,630,986 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
19,970 | $2,630,847 |
All Filings in LQDA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,701,224 | 204,060 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,875,986 | 112,380 | Shares | Sole | 2026-02-17 | |
| 2021-03-31 | $39,596 | 14,720 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||